$0.20
2.70%
Nasdaq, Fri, Dec 27 2024
ISIN
US75973T1016
Symbol
RNLX

Renalytix Plc - ADR Target price 2024 - Analyst rating & recommendation

Renalytix Plc - ADR Classifications & Recommendation:

Buy
100%

Renalytix Plc - ADR Price Target

Target Price $3.00
Price $0.20
Potential
Number of Estimates 1
1 Analyst has issued a Renalytix Plc - ADR price target 2025. The average Renalytix Plc - ADR target price is $3.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend Renalytix Plc - ADR to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Renalytix Plc - ADR stock has an average upside potential 2025 of . Most analysts recommend the Renalytix Plc - ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million $ 2.29 4.40
32.65% 92.14%
Net Margin -2,246.08% -1,192.78%
17.07% 46.90%

1 Analyst has issued a sales forecast Renalytix Plc - ADR 2025 . The average Renalytix Plc - ADR sales estimate is

$4.4m
Unlock
. This is
87.23% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$4.4m 87.23%
Unlock
, the lowest is
$4.4m 87.23%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.3m 32.65%
2025
$4.4m 92.14%
Unlock

The average Renalytix Plc - ADR net profit estimate is

$-52.5m
Unlock
. This is
24.04% lower
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-51.4m 44.14%
2025
$-52.5m 2.03%
Unlock

Net Margin

2024 -2,246.08% 17.07%
2025
-1,192.78% 46.90%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share $ -0.62 -0.68
44.14% 9.68%
P/E negative
EV/Sales 4.12

The average Renalytix Plc - ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.68
Unlock
. This is
33.33% lower
Unlock
than earnings per share in the financial year 2024.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.62 44.14%
2025
$-0.68 9.68%
Unlock

P/E ratio

Current -0.39 7.14%
2025
-0.22 43.59%
Unlock

Based on analysts' sales estimates for 2025, the Renalytix Plc - ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 17.11 175.52%
2025
4.12 75.94%
Unlock

P/S ratio

Current 13.99 89.87%
2025
3.24 76.85%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today